Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

A DNA microarray or chip is a semiconductor surface on which sequences of many varied genes are bonded to probes. DNA microarrays are used to quantify expression levels of numbers of genes simultaneously or to genotype multiple regions of a genome. The approach finds application in drug R&D, clinical diagnosis, agriculture, environment control, and other sectors.

The global DNA/gene microarray market is estimated to account for US$ 3,018.3 Mn in terms of value in 2020 and is expected to reach US$ 7,693.0 Mn by the end of 2027.

Global DNA/Gene Microarray Market: Drivers

Increasing adoption of genetic testing is expected to propel growth of the global DNA/gene microarray market over the forecast period. For instance, in April 2020, Axovant Gene Therapies collaborated with Invitae Corporation, a provider of advanced medical genetics, to offer free genetic testing in the U.S. and Canada for pediatric lysosomal storage disease.

Moreover, development of novel microarray technology is also expected to fuel growth of the global DNA/gene microarray market over the forecast period. For instance, in December 2019, PathogenDx, Inc. was awarded two US Patents for Tandem PCR + Microarray Hybridisation technology.

North America held dominant position in the global DNA/gene microarray market in 2019, accounting for 34.1% share in terms of value, followed by Europe and Asia Pacific, respectively

Figure 1. Global DNA/Gene Microarray Market Share (%), by Value, by Region, 2019

DNA/Gene Microarray  | Coherent Market Insights

Global DNA/Gene Microarray Market: Restraints

Lack of technically trained resources, especially in emerging economies, is expected to hinder growth of the global DNA/gene microarray market. Technologically versed and skilled resources are a prerequisite for using DNA/gene microarrays and sequencers. Shortage of such trained personnel is expected to limit market growth.

Moreover, chip compatibility issues are also expected to limit the market growth. A company’s microarray is compatible only with its scanner, fluidics station, autoloader, and operating software alone wherein the manufacturers strive to maintain proprietary rights by following a closed system. Such system specificity principle is believed to create entry barriers for upcoming and new players in the market.

Global DNA/Gene Microarray Market: Opportunities 

R&D in cancer is expected to offer lucrative growth opportunities for players in the market. For instance, in April 2020, researchers from National Defense Medical Center, Taiwan, reported use of DNA microarray gene expression profiles in a research to assess the immunofunctionomes of ovarian clear cell carcinoma in early and advanced stages.

Moreover, increasing prevalence of cancer is also expected to aid in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

The global DNA/gene microarray market was valued at US$ 2,640.7 Mn in 2019 and is forecast to reach a value of US$ 7,693.0 Mn by 2027 at a CAGR of 12.4% between 2020 and 2027.

Figure 2. Global DNA/Gene Microarray Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

DNA/Gene Microarray  | Coherent Market Insights

Market Trends/Key Takeaways

DNA microarray is effective and accurate in determining the presence of pathogens in cannabis. According to a November 2019 study results released by PathogenDx, Inc., end-point PCR technologies such as Sequencing and DNA microarray are more accurate in determining the presence of pathogens in cannabis.

Single Nucleotide Polymorphism (SNP) chips have found to give false positive results. According to a study published in the journal bioRxiv in June 2019, SNP chips used by direct-to-consumer genetic testing companies have a false discovery rate of over 85% when screening for very rare variants.

Global DNA/Gene Microarray Market: Competitive Landscape  

Major players operating in the global DNA/gene microarray market include, Affymetrix, Inc., Illumina, Inc., Agilent Technologies Inc., Roche NimbleGen Inc., Sequenom, Inc., Biometrix Technology Inc., LC Sciences, Life Technologies Corp., Lifegen Technologies LLC, Microarrays Inc.

Global DNA/Gene Microarray Market: Key Developments  

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in March 2020, Agilent Technologies Inc. launched Agilent GenetiSure Cyto microarrays for prenatal and postnatal research.

Major players in the market are also focused on adopting collaboration and partnership strategies to enhance their market share. For instance, in July 2019, PathogenDx, Inc. entered into a strategic sales and service distribution partnership with Zef Scientific in Canada.

DNA Chips, Biochips or DNA microarrays consists of a microscope slide made materials such as glass, silicon chips, and nylon membrane, which is printed with thousands of minute spots. These spots contain a known DNA sequence or gene in an orderly sequence. DNA microarray uses nucleic acid hybridization principle and type of DNA microarrays include cDNA microarrays, Oligo DNA microarrays, BAC microarrays, and SNP microarrays. Applications of DNA chips include study of transcriptomes and proteomes, diagnosis of diseases, identification of microbes, and others

Restraints of the Global DNA/Gene Microarray Market

The high cost involved in R&D of DNA/Gene microarray technology-based products and limited financial support has posed a great challenge to growth of the global DNA/Gene microarray market. Manufacturing complexity of the biochip technology and research and development that is required to bring out innovative biochips in the market results in high costs of these products.

Key features of the study:

  • This report provides in-depth analysis of the global DNA/Gene microarray market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global DNA/Gene microarray market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Affymetrix, Inc., Illumina, Inc., Agilent Technologies Inc., Roche NimbleGen Inc., Sequenom, Inc., Biometrix Technology Inc., LC Sciences, Life Technologies Corp., Lifegen Technologies LLC, Microarrays Inc..
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global DNA/Gene microarray market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global DNA/Gene Microarray Market, By Type:
    • oDNA
    • cDNA
  • Global DNA/Gene Microarray Market, By Application:
    • Genomics
    • Proteomics
    • Agricultural biology
    • Environment
    • Drug R&D
    • Gene expression and SNP analysis
    • Cancer/oncology
    • Others
  • Global DNA/Gene Microarray Market, By Geography:
    • North America
      • By Type
        • oDNA
        • cDNA
      • By Application
        • Genomics
        • Proteomics
        • Agricultural biology
        • Environment
        • Drug R&D
        • Gene expression and SNP analysis
        • Cancer/oncology
        • Others
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Type
        • oDNA
        • cDNA
      • By Application
        • Genomics
        • Proteomics
        • Agricultural biology
        • Environment
        • Drug R&D
        • Gene expression and SNP analysis
        • Cancer/oncology
        • Others
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Type
        • oDNA
        • cDNA
      • By Application
        • Genomics
        • Proteomics
        • Agricultural biology
        • Environment
        • Drug R&D
        • Gene expression and SNP analysis
        • Cancer/oncology
        • Others
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Type
        • oDNA
        • cDNA
      • By Application
        • Genomics
        • Proteomics
        • Agricultural biology
        • Environment
        • Drug R&D
        • Gene expression and SNP analysis
        • Cancer/oncology
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East:
      • By Type
        • oDNA
        • cDNA
      • By Application
        • Genomics
        • Proteomics
        • Agricultural biology
        • Environment
        • Drug R&D
        • Gene expression and SNP analysis
        • Cancer/oncology
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Type
        • oDNA
        • cDNA
      • By Application
        • Genomics
        • Proteomics
        • Agricultural biology
        • Environment
        • Drug R&D
        • Gene expression and SNP analysis
        • Cancer/oncology
        • Others
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Affymetrix, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Illumina, Inc.
    • Agilent Technologies Inc.
    • Roche NimbleGen Inc.
    • Sequenom, Inc.
    • Biometrix Technology Inc.
    • LC Sciences
    • Life Technologies Corp.
    • Lifegen Technologies LLC
    • Microarrays Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Type
      • Market Snippet, By Application
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
  4. Global DNA/Gene Microarray Market, By Type, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • oDNA
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • cDNA
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
  5. Global DNA/Gene Microarray Market, By Application, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Genomics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Proteomics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Agricultural biology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Environment
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Drug R&D
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Gene expression and SNP analysis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Cancer/oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global DNA/Gene Microarray Market, By Regions, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Company Profiles
      • Affymetrix, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Illumina, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Agilent Technologies Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Roche NimbleGen Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Sequenom, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Biometrix Technology Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • LC Sciences
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Life Technologies Corp.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Lifegen Technologies LLC
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Microarrays Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 28 market data tables and 26 figures on “DNA/Gene Microarray Market – Global forecast to 2027.

Frequently Asked Questions

The global DNA/Gene Microarray market was valued at US$ 2,640.7 Mn in 2019 and is forecast to reach a value of US$ 7,693.0 Mn by 2027 at a CAGR of 12.4% between 2020 and 2027.
oDNA segment held the major market share in 2019 owing to increasing demand for DNA based research.
Major factor driving the growth of global DNA/Gene Microarray market during the forecast period include increasing genetic testing, and developments in microarray technology.
Major factors hampering the growth of the DNA/Gene Microarray market during the forecast period constitutes of high costs, and compatibility issues.
North America DNA/Gene Microarray market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Affymetrix, Inc., Illumina, Inc., Agilent Technologies Inc., Roche NimbleGen Inc., Sequenom, Inc., Biometrix Technology Inc., LC Sciences, Life Technologies Corp., Lifegen Technologies LLC, Microarrays Inc.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner